AKT1 and neoplasm: Although triol treatment suppressed cell proliferation, migration, invasion, and tumor growth in all three of these different prostate cancer cells, it may target different signaling proteins involved in the same pathways (such as Akt signaling) or similar functions (such as regulation of cell cycle, EMT, and cell structure) to produce similar results in different cell lines.